1-[(11Z)-octadecenoyl]-2-[(4Z,7Z,10Z,13Z,16Z,19Z)]-docosahexaenoyl-sn-glycero-3-phosphocholine

Term ID

CHEBI:84812

Synonyms

(2R)-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyloxy]-3-[(11Z)-octadec-11-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate
1-Vaccenoyl-2-docosahexaenoyl-sn-glycero-3-phosphocholine
GPCho(18:1/22:6)
GPCho(18:1n7/22:6n3)
GPCho(18:1w7/22:6w3)
PC(18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(18:1/22:6)
PC(18:1n7/22:6n3)
PC(18:1w7/22:6w3)
Phosphatidylcholine(18:1/22:6)
Phosphatidylcholine(18:1n7/22:6n3)

Definition

A phosphatidylcholine 40:7 in which the acyl groups at C-1 and C-2 are (11Z)-octadecenoyl and (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl respectively.

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: phosphatidylcholine 40:7

phosphatidylcholine 40:7 Show first 5 Terms
has_functional_parent: all-cis-docosa-4,7,10,13,16,19-hexaenoic acid cis-vaccenic acid

all-cis-docosa-4,7,10,13,16,19-hexaenoic acid cis-vaccenic acid Show first 5 Terms
has_role: mouse metabolite

mouse metabolite Show first 5 Terms

Phenotype

Phenotype resulting from 1-[(11Z)-octadecenoyl]-2-[(4Z,7Z,10Z,13Z,16Z,19Z)]-docosahexaenoyl-sn-glycero-3-phosphocholine

Phenotype where environments contain 1-[(11Z)-octadecenoyl]-2-[(4Z,7Z,10Z,13Z,16Z,19Z)]-docosahexaenoyl-sn-glycero-3-phosphocholine

Phenotype modified by environments containing 1-[(11Z)-octadecenoyl]-2-[(4Z,7Z,10Z,13Z,16Z,19Z)]-docosahexaenoyl-sn-glycero-3-phosphocholine

Human Disease Model